Cleared Traditional

K143610 - BD INTIMA II CLOSED IV CATHETER

K143610 is an FDA 510(k) clearance for BD INTIMA II CLOSED IV CATHETER, manufactured by Becton Dickinson Infusion Therapy Systems, Inc.. The device is a Class 2 General Hospital device with product code FOZ cleared through the Traditional 510(k) pathway after a 111-day FDA review.

K143610 · Becton Dickinson Infusion Therapy Systems, Inc. · General Hospital
Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Apr 2015
Decision
111d
Days
Class 2
Risk

K143610 is an FDA 510(k) clearance for the BD INTIMA II CLOSED IV CATHETER. Classified as Catheter, Intravascular, Therapeutic, Short-term Less Than 30 Days (product code FOZ), Class II - Special Controls.

Submitted by Becton Dickinson Infusion Therapy Systems, Inc. (Sandy, US). The FDA issued a Cleared decision on April 9, 2015 after a review of 111 days - within the typical 510(k) review window.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5200 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General Hospital review framework, consistent with the majority of Class II 510(k) submissions.

FDA 510(k) Submission Details - K143610

510(k) Number K143610 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 19, 2014
Decision Date April 09, 2015
Days to Decision 111 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
18d faster than avg
Panel avg: 129d · This submission: 111d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

FOZ Device Classification - Class 2, Special Controls

Product Code FOZ Catheter, Intravascular, Therapeutic, Short-term Less Than 30 Days
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5200
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FOZ Catheter, Intravascular, Therapeutic, Short-term Less Than 30 Days

All 507
Devices cleared under the same product code (FOZ) and FDA review panel - the closest regulatory comparables to K143610.
I.V. Catheter
K142797 · Jiangxi Sanxin Medtec Co., Ltd. · Jun 2015
Arrow Pressure Injectable Jugular Axillo-subclavian Central Catheter (JACC) with Sustain Technology
K150109 · Arrow International (A Subsidiary of Teleflex, Inc.) · Jun 2015
BioFlo Midline Catheter
K150407 · Navilyst Medical, Inc. · May 2015
ACCUCATH MIDLINE CATHETER SYSTEM
K142136 · Vascular Pathways, Inc. · Jan 2015
NEXUS MIDLINE CT CATHETER
K140270 · Health Line International Corporation · Aug 2014
LEADERFLEX
K141026 · Vygon · Jul 2014
K143610 · BD INTIMA II CLOSED IV CATHETER
Download PDF FDA Summary Becton Dickinson Infu…